Phys Vivas · rheumatological
Sjögren Syndrome and Inflammatory Myopathies — Viva Defence
DCE viva defence for Sjögren Syndrome and Inflammatory Myopathies.
On this page
Study tools
Target exams
Sjögren Syndrome and Inflammatory Myopathies Viva
Long Case Viva Defence
Opening statement
"This patient presents with a problem best framed as Sjögren Syndrome and Inflammatory Myopathies. My priorities are to identify red flags, confirm the mechanism with purposeful investigations, start a sequenced management plan, and integrate multimorbidity and follow-up."
Examiner questions
Q1: "What makes this urgent?"
"I look for threats to airway, perfusion, neurology, metabolism, infection or bleeding, and I escalate those before elective work-up."
Q2: "What is your first investigation package?"
"I order tests that change management now, not a scattergun panel."
Q3: "Walk me through treatment."
"Stabilise, treat the mechanism, prevent complications, and plan monitoring."
Q4: "What is the classic trap?"
"Treating a label without confirming the discriminating mechanism, or delaying escalation."
References5ShowHide
- [4]Shiboski CH, Shiboski SC, Seror R, et al. 2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts Arthritis Rheumatol, 2017.PMID 27785888
- [5]Lundberg IE, Tjärnlund A, Bottai M, et al. 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups Ann Rheum Dis, 2017.PMID 29079590
- [6]Alexander T, Roldan E, Del Papa N, Farge D, et al. Autologous haematopoietic stem cell transplantation for rheumatic diseases: best practice recommendations from the EBMT Practice Harmonization and Guidelines Committee Bone Marrow Transplant, 2025.PMID 40830237
- [7]Rüegg L, Pluma A, Hamroun S, Cecchi I, et al. EULAR recommendations for use of antirheumatic drugs in reproduction, pregnancy, and lactation: 2024 update Ann Rheum Dis, 2025.PMID 40287311
- [8]Xanthouli P, Schatz A, Bergner R, Triantafyllias K [Management of pulmonary and cardiovascular comorbidities in rheumatological diseases] Z Rheumatol, 2025.PMID 40736566